It's nice to have independent confirmation that leronlimab works in cells against HIV viral isolates where other classes of drugs failed, and this effectiveness was not lessened by current or previous exposure to maraviroc.

Quote:

---

... leronlimab might represent a promising candidate for salvage therapy in one third of individuals included in this study with CCR5-coreceptor using viral populations.

---